Could a probiotic prevent autoimmune disease? The role of L. johnsonii in mitigating Type 1 Diabetes

Type 1 Diabetes is an autoimmune disease in which a person's own immune system destroys their insulin-producing cells. Researchers have been investigating the use of a probiotic, Lactobacillus johnsonii N6.2, to reduce the risk. In this talk, we cover 3 exciting papers on this topic, sharing some background on what Type 1 Diabetes is, results of Phase 1 clinical trials in humans, and the molecular mechanisms at work behind the scenes.